Show Summary Details
Page of

Pharmacology of Antiretroviral Therapies 

Pharmacology of Antiretroviral Therapies
Pharmacology of Antiretroviral Therapies

Scott L. Letendre

, J. Allen McCutchan

, Ronald J. Ellis

, Brookie M. Best

, and Edmund V. Capparelli

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 July 2020

After more than a decade of widespread use, combination antiretroviral therapy has not reduced the prevalence of HIV-associated neurocognitive disorders (HAND). Low drug concentrations in the brain, due to poor drug penetration of the blood-brain barrier by many antiretroviral therapies (ART), may partially explain why HAND persists or develops in treated patients. In this chapter, we review the relevant pharmacology of ART and accumulating evidence that the use of antiretrovirals that reach therapeutic concentrations in the central nervous system (CNS) are the best options to prevent and treat HIV-induced brain injury. Topics covered include an overview of the problem, pharmacokinetics of ART in the CNS, determinants of CNS penetration by ART, means of estimating CNS penetration by ART, pharmacodynamics of ART in the CNS, and the development of a clinically useful metric for the CNS effectiveness of antiretroviral drugs.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.